MSA Capital is a Beijing-based global venture capital firm with $1.5 billion under management, investing from seed to growth. MSA invested in Chinese gene sequencing, mobility, SaaS, consumer internet companies. Notable portfolio companies include Meituan, Didi, Mobike, NIO, Beijing Genomic Institute, Zhaogang, Tuija, and Mogujie. MSA’s LP base is composed of regional and global institutional investors, as well as leading Chinese technology entrepreneurs.